134 related articles for article (PubMed ID: 18614574)
1. Foveal contrast processing of increment and decrement targets is equivalently reduced in glaucoma.
Sampson GP; Badcock DR; Walland MJ; McKendrick AM
Br J Ophthalmol; 2008 Sep; 92(9):1287-92. PubMed ID: 18614574
[TBL] [Abstract][Full Text] [Related]
2. Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.
Battista J; Badcock DR; McKendrick AM
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1221-6. PubMed ID: 18936145
[TBL] [Abstract][Full Text] [Related]
3. Contrast sensitivity changes due to glaucoma and normal aging: low-spatial-frequency losses in both magnocellular and parvocellular pathways.
McKendrick AM; Sampson GP; Walland MJ; Badcock DR
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2115-22. PubMed ID: 17460269
[TBL] [Abstract][Full Text] [Related]
4. Psychophysical measurement of neural adaptation abnormalities in magnocellular and parvocellular pathways in glaucoma.
McKendrick AM; Badcock DR; Morgan WH
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1846-53. PubMed ID: 15161849
[TBL] [Abstract][Full Text] [Related]
5. The detection of both global motion and global form is disrupted in glaucoma.
McKendrick AM; Badcock DR; Morgan WH
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3693-701. PubMed ID: 16186351
[TBL] [Abstract][Full Text] [Related]
6. Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.
Sun H; Swanson WH; Arvidson B; Dul MW
Vision Res; 2008 Nov; 48(26):2633-41. PubMed ID: 18501947
[TBL] [Abstract][Full Text] [Related]
7. Visual contrast sensitivity alterations in inferred magnocellular pathways and anomalous perceptual experiences in people at high-risk for psychosis.
Kéri S; Benedek G
Vis Neurosci; 2007; 24(2):183-9. PubMed ID: 17640409
[TBL] [Abstract][Full Text] [Related]
8. Elevated vernier acuity thresholds in glaucoma.
McKendrick AM; Johnson CA; Anderson AJ; Fortune B
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1393-9. PubMed ID: 11980852
[TBL] [Abstract][Full Text] [Related]
9. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
McKendrick AM; Sampson GP
Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
[TBL] [Abstract][Full Text] [Related]
10. Effects of glaucoma and aging on photopic and scotopic motion perception.
Willis A; Anderson SJ
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):325-35. PubMed ID: 10634638
[TBL] [Abstract][Full Text] [Related]
11. Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision.
Zele AJ; Pokorny J; Lee DY; Ireland D
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3622-31. PubMed ID: 17652732
[TBL] [Abstract][Full Text] [Related]
12. Impairments of contrast discrimination and contrast adaptation in glaucoma.
McKendrick AM; Sampson GP; Walland MJ; Badcock DR
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):920-7. PubMed ID: 19741250
[TBL] [Abstract][Full Text] [Related]
13. Contrast sensitivity for flickering and static letters and visual acuity at isoluminance in glaucoma.
Swindale NV; Fendick MG; Drance SM; Graham SL; Hnik P
J Glaucoma; 1996 Jun; 5(3):156-69. PubMed ID: 8795753
[TBL] [Abstract][Full Text] [Related]
14. Achromatic parvocellular contrast gain in normal and color defective observers: Implications for the evolution of color vision.
Lutze M; Pokorny J; Smith VC
Vis Neurosci; 2006; 23(3-4):611-6. PubMed ID: 16962004
[TBL] [Abstract][Full Text] [Related]
15. A Novel Motion-on-Color Paradigm for Isolating Magnocellular Pathway Function in Preperimetric Glaucoma.
Wen W; Zhang P; Liu T; Zhang T; Gao J; Sun X; He S
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4439-46. PubMed ID: 26193920
[TBL] [Abstract][Full Text] [Related]
16. Psychophysical assessment of magno- and parvocellular function in schizophrenia.
Delord S; Ducato MG; Pins D; Devinck F; Thomas P; Boucart M; Knoblauch K
Vis Neurosci; 2006; 23(3-4):645-50. PubMed ID: 16962008
[TBL] [Abstract][Full Text] [Related]
17. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
[TBL] [Abstract][Full Text] [Related]
18. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy.
Gualtieri M; Bandeira M; Hamer RD; Costa MF; Oliveira AG; Moura AL; Sadun F; De Negri AM; Berezovsky A; Salomão SR; Carelli V; Sadun AA; Ventura DF
Vis Neurosci; 2008; 25(3):469-74. PubMed ID: 18598420
[TBL] [Abstract][Full Text] [Related]
19. Psychophysical signatures associated with magnocellular and parvocellular pathway contrast gain.
Pokorny J; Smith VC
J Opt Soc Am A Opt Image Sci Vis; 1997 Sep; 14(9):2477-86. PubMed ID: 9291615
[TBL] [Abstract][Full Text] [Related]
20. Glaucoma affects steady state VEP contrast thresholds before psychophysics.
Vaegan ; Rahman AM; Sanderson GF
Optom Vis Sci; 2008 Jul; 85(7):547-58. PubMed ID: 18594348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
